Home/Filings/4/0000899243-17-008372
4//SEC Filing

Pulmatrix, Inc. 4

Accession 0000899243-17-008372

$PULMCIK 0001574235operating

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 3:57 PM ET

Size

9.9 KB

Accession

0000899243-17-008372

Insider Transaction Report

Form 4
Period: 2017-03-20
Clarke Robert W.
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-03-22$2.21/sh+4,525$10,0004,525 total
  • Award

    Stock Option (Right to Buy)

    2017-03-20+159,000159,000 total
    Exercise: $2.78Exp: 2027-03-20Common Stock (159,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-03-224,5252,665 total
    Exercise: $2.21Exp: 2020-02-10Common Stock (4,525 underlying)
Footnotes (3)
  • [F1]The option vests as to 25% on March 20, 2018 and the remaining 75% vests in thirty-six (36) equal monthly installments with 2.083% vesting for each of the next thirty-six (36) months that follow March 20, 2018, subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
  • [F2]The option, representing the right to purchase a total of 7,190 shares of common stock, was fully vested and exercisable as of February 10, 2014.
  • [F3]On March 22, 2017, the Reporting Person acquired 4,525 shares of common stock upon a partial exercise of this option. Following the exercise, the Reporting Person may acquire an additional 2,665 shares of common stock pursuant to this option.

Issuer

Pulmatrix, Inc.

CIK 0001574235

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001574235

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 3:57 PM ET
Size
9.9 KB